Stay updated on RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.

Latest updates to the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe record history now shows Revision: v3.6.5 replacing the previous Revision: v3.6.4. This update reflects a new page release being tracked in the history log.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a new revision entry in the study record history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedVersion 22 of the study record was released, updating the Study Status to Completed and the Recruitment Status to No longer recruiting, with a revision note of v3.6.3. It also reflects the removal of the previous Active, not recruiting status.SummaryDifference0.6%

- Check49 days agoChange DetectedA new revision entry for v3.6.2 was added to the study's history. This updates the record's version history to reflect the latest change and helps track updates over time.SummaryDifference0.1%

- Check63 days agoChange DetectedThe recruitment status was updated to 'No longer looking for participants' to reflect that enrollment has ended. The version history now shows a new revision 'Revision: v3.6.0' and removes the previous 'Revision: v3.5.5'.SummaryDifference0.3%

- Check70 days agoChange DetectedA new revision entry 'Revision: v3.5.5' was added to the history while the previous 'Revision: v3.5.4' was removed, updating the page's version history to reflect the latest revision.SummaryDifference0.1%

Stay in the know with updates to RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAMP204: Avutometinib + Adagrasib in KRAS G12C NSCLC Clinical Trial page.